Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Invariant Natural Killer T Cells from Donor Lymphocyte Infusions (DLI-iNKTs) Contribute to Anti-Tumor Immunity after Allogeneic Hematopoietic Cell Transplantation

Simona Jahnke, Hannes Schmid, MSc, Kathy-Ann Secker, MSc, Silke Duerr-Stoerzer, Hildegard Keppeler, Rebecca Baur, Michael Schumm, Dr. MD vet., Rupert Handgretinger, MD PhD, Wolfgang Bethge, MD, Lothar Kanz, Corina Schneidawind, MD, Dominik Schneidawind, MD

Blood (2018) 132 (Supplement 1): 3340.

https://doi.org/10.1182/blood-2018-99-111745

Published: 2018

Journal Articles

Prophylaxis of Chemotherapy-Induced Nausea and Vomiting with Fosaprepitant and Granisetron in Pediatric Patients after Allogeneic HSCT

Karin Melanie Cabanillas Stanchi, MSc, Julia Vek, Dr. MD, Patrick Schlegel, MD, Christian M. Seitz, MD, Joachim Rupprecht, Dr. MD, Sarah Schober, Dr. MD, Sebastian Michaelis, Dr. MD, Carmen Malaval, Dr. MD, Tim Flaadt, Dr. MD, Lukas Schnaufer, Dr. MD, Manon Queudeville, Dr. MD, Judith Feucht, Dr. MD, Peter Lang, MD, Rupert Handgretinger, MD PhD, Michaela Döring, Dr. MD

Blood (2018) 132 (Supplement 1): 3388.

https://doi.org/10.1182/blood-2018-99-112762

Published: 2018

Journal Articles

Procalcitonin and C-Reactive Protein during Transplant-Related Adverse Events after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients

Karin Melanie Cabanillas Stanchi, MSc, Melinda Eikemeier, Dr. MD, Peter Lang, MD, Rupert Handgretinger, MD PhD, Michaela Döring, Dr. MD

Blood (2018) 132 (Supplement 1): 2102.

https://doi.org/10.1182/blood-2018-99-113865

Published: 2018

Journal Articles

Results of a Prospective, Multicenter, Phase I/II Clinical Study in Pediatric and Adult Patients Using TCR Alpha/Beta and CD19 Depleted Haploidentical Hematopoietic Stem Cell Grafts Following Reduced-Intensity Conditioning

Blood (2018) 132 (Supplement 1): 604.

https://doi.org/10.1182/blood-2018-99-110124

Published: 2018

Journal Articles

Combinatorial Targeting of Multiple Shared Antigens By Adapter-CAR-T Cells (aCAR-Ts) Allows Target Cell Discrimination and Specific Lysis Based on Differential Expression Profiles

Christian M. Seitz, MD, Verena Kieble, cand.MD, Clara Illi, cand. MD, Selina Reiter, cand. MD, Stefan Grote, MSc, Joerg Mittelstaet, PhD, Dominik Lock, M.Sc., Andrew Kaiser, PhD, Sabine Schleicher, PhD, Rupert Handgretinger, MD PhD, Peter Lang, MD, Patrick Schlegel, MD

Blood (2018) 132 (Supplement 1): 4543.

https://doi.org/10.1182/blood-2018-99-115630

Published: 2018

Journal Articles

Adapter Chimeric Antigen Receptor (aCAR)-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Universal Tumor Targeting

Stefan Grote, MSc, Christian M. Seitz, MD, Simon Diepold, cand. MD, Markus Buchner, cand. MD, Caroline Baden, Elke Malenke, Sophie Marie Dieckmann, Hanna Schwaemmle, Joerg Mittelstaet, PhD, Andrew Kaiser, PhD, Patrick Schlegel, MD, Rupert Handgretinger, MD PhD, Sabine Schleicher, PhD

Blood (2018) 132 (Supplement 1): 3331.

https://doi.org/10.1182/blood-2018-99-116724

Published: 2018

Journal Articles

High Molecular Remission Rate in Pediatric Patients (pts) with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (r/r ALL) Treated with Blinatumomab: Rialto an Open-Label, Multicenter, Expanded Access Study

Franco Locatelli, Gerhard Zugmaier, Peter Bader, MD PhD, Sima Jeha, MD, Paul-Gerhardt Schlegel, MD, Jean-Pierre Bourquin, MD PhD, Rupert Handgretinger, MD PhD, Benoit Brethon, Claudia Rossig, MD, Christiane Chen-Santel, MD

Blood (2018) 132 (Supplement 1): 1375.

https://doi.org/10.1182/blood-2018-99-109855

Published: 2018

Journal Articles

AML SCT-BFM 2007: Results of the Prospective Hematopoietic Stem Cell Transplantation (HCT) Trial of the Berlin-Frankfurt-MÃ¼nster (BFM) Study Group for Children with Very High Risk Acute Myeloid Leukemia

Blood (2017) 130 (Supplement 1): 599.

https://doi.org/10.1182/blood.V130.Suppl_1.599.599

Published: 2017

Journal Articles

First Results of a Prospective Multicenter Phase I/II Clinical Trial in Adult Patients Using Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning

Wolfgang Bethge, MD, Stephan Mielke, MD, Dietger Niederwieser, MD, Roland Meisel, MD, Donald w. Bunjes, MD, Arne Brecht, MD, Jurgen Kuball, MD, Sandra Karitzky, PhD, Silke Holtkamp, Christiane Siewert, PhD, Stefanie Pflitsch, Michael Schumm, DVM, Matthias K. Eyrich, MD, Vladan Vucinic, Markus Wiesneth, MD, Kasper Westinga, Rupert Handgretinger, MD PhD

Blood (2017) 130 (Supplement 1): 213.

https://doi.org/10.1182/blood.V130.Suppl_1.213.213

Published: 2017

Journal Articles

Safety and Efficacy of Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: Results of a Prospective Multicenter Phase I/II Clinical Trial

Peter J. Lang, MD, Paul G. Schlegel, MD, Roland Meisel, MD, Ansgar S. Schulz, MD, Johann Greil, MD, Peter Bader, MD PhD, Sandra Karitzky, PhD, Silke Holtkamp, Christiane Siewert, PhD, Stefanie Pflitsch, Michael Schumm, DVM, Matthias K. Eyrich, MD, Markus Wiesneth, MD, Halvard Bonig, MD MA, Rupert Handgretinger, MD PhD

Blood (2017) 130 (Supplement 1): 214.

https://doi.org/10.1182/blood.V130.Suppl_1.214.214

Published: 2017

Journal Articles

High Rates of Minimal Residual Disease-Negative (MRD−) Complete Responses (CR) in Adult and Pediatric and Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL) Treated With KTE-C19 (Anti-CD19 Chimeric Antigen Receptor [CAR] T Cells): Preliminary Results of the ZUMA-3 and ZUMA-4 Trials

Blood (2016) 128 (22): 2803.

https://doi.org/10.1182/blood.V128.22.2803.2803

Published: 2016

Journal Articles

Surface HLA-DR Expression in Monocyte Subpopulations During Adverse Events After Hematopoietic Stem Cell Transplantation

Michaela Döring, MD, Susanne Haufe, MS, Annika Erbacher, MD, Ingo Müller, MD, PhD, Rupert Handgretinger, MD, PhD, Michael Hofbeck, MD, PhD, Gunter Kerst, MD, PhD

Blood (2011) 118 (21): 2161.

https://doi.org/10.1182/blood.V118.21.2161.2161

Published: 2011

Journal Articles

Retrospective Analysis of Itraconacole, Voriconazole and Posaconazole As Oral Antifungal Prophylaxis in Pediatric Patients Following Allogeneic Stem Cell Transplantation

Michaela Döring, MD, Olivia Blume, MS, Susanne Haufe, MS, Ulrike Hartmann, Pharmacologist, Astrid Kimmig, MD, Carl-Philipp Schwarze, MD, Rupert Handgretinger, MD, PhD, Ingo Müller, MD, PhD

Blood (2011) 118 (21): 3011.

https://doi.org/10.1182/blood.V118.21.3011.3011

Published: 2011

Journal Articles

Effect of the HDAC Inhibitor SAHA on the Immunmodulatory Properties of MSC and Tumor Stroma Cells.

Anne Kruchen, Pascal-David Johann, Rupert Handgretinger, MD, PhD, Ingo Müller, MD

Blood (2010) 116 (21): 2592.

https://doi.org/10.1182/blood.V116.21.2592.2592

Published: 2010

Journal Articles

Adoptive Transfer of EBNA1-Specific T-Cells as a Treatment of Epstein-Barr-Virus Reactivation Following Allogeneic Stem Cell Transplantation

Vanya Icheva, Kathrin Opherk, Wolfgang A. Bethge, Simone Kayser, Johann Greil, MD, Rupert Handgretinger, MD, PhD, Peter Lang, Tobias F. Feuchtinger, MD

Blood (2010) 116 (21): 2342.

https://doi.org/10.1182/blood.V116.21.2342.2342

Published: 2010

Journal Articles

Use of IL15 Stimulated, CD3/19 Depleted Transplants From Haploidentical Donors In Pediatric Malignancies

Peter Lang, Matthias Pfeiffer, Heiko-Manuel Teltschik, Tobias F. Feuchtinger, MD, Martin Ebinger, Ingo Mueller, Michael Schumm, Rupert Handgretinger, MD, PhD

Blood (2010) 116 (21): 3548.

https://doi.org/10.1182/blood.V116.21.3548.3548

Published: 2010

Journal Articles

Siglec-7 Tetramers Characterize B Cell Subpopulations and Identify Immunomodulatory Ligands on Malignant Cells

Philippa Mang, Friederike Gieseke, PhD, Susanne Viebahn, PhD, Inga Gondesen, Anne Kruchen, Annika Erbacher, PhD, Matthias Pfeiffer, MD, Rupert Handgretinger, MD, PhD, Ingo Müller, MD

Blood (2010) 116 (21): 1728.

https://doi.org/10.1182/blood.V116.21.1728.1728

Published: 2010

Journal Articles

Patterns of HLA-DR Surface Expression on CD14+ Monocytes During Adverse Events After Hematopoietic Stem Cell Transplantation.

Michaela Döring, MD, Ingo Müller, MD, Annika Erbacher, Rupert Handgretinger, MD, PhD, Michael Hofbeck, MD, PhD, Gunter Kerst, MD

Blood (2010) 116 (21): 1499.

https://doi.org/10.1182/blood.V116.21.1499.1499

Published: 2010

Journal Articles

Allogeneic Hematopoetic Stem Cell Transplantation (SCT) In Children with ALL: Outcome of Matched Sibling Donor SCT (MSD-SCT) Is Equivalent to Unrelated Well Matched Donor HSCT (MD-HSCT) A Report From the Prospective International Multicenter Trial ALL-SCT-BFM 2003

Blood (2010) 116 (21): 530.

https://doi.org/10.1182/blood.V116.21.530.530

Published: 2010

Journal Articles

Hematopoietic Stem Cell Therapy In Eight Patients with Metachromatic Leukodystrophy – Relevance of Post-Transplant Medication.

Judith Böhringer, Birgit Kustermann-Kuhn, PhD, Friederike Gieseke, PhD, Annika Erbacher, PhD, Michaela Döring, MD, Christiane Kehrer, MD, Peter Lang, MD, Ingeborg Krägeloh-Mann, MD, Rupert Handgretinger, MD, PhD, Ingo Müller, MD

Blood (2010) 116 (21): 3727.

https://doi.org/10.1182/blood.V116.21.3727.3727

Published: 2010

NARROW

Invariant Natural Killer T Cells from Donor Lymphocyte Infusions (DLI-iNKTs) Contribute to Anti-Tumor Immunity after Allogeneic Hematopoietic Cell Transplantation

Prophylaxis of Chemotherapy-Induced Nausea and Vomiting with Fosaprepitant and Granisetron in Pediatric Patients after Allogeneic HSCT

Procalcitonin and C-Reactive Protein during Transplant-Related Adverse Events after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients

Results of a Prospective, Multicenter, Phase I/II Clinical Study in Pediatric and Adult Patients Using TCR Alpha/Beta and CD19 Depleted Haploidentical Hematopoietic Stem Cell Grafts Following Reduced-Intensity Conditioning

Combinatorial Targeting of Multiple Shared Antigens By Adapter-CAR-T Cells (aCAR-Ts) Allows Target Cell Discrimination and Specific Lysis Based on Differential Expression Profiles

Adapter Chimeric Antigen Receptor (aCAR)-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Universal Tumor Targeting

High Molecular Remission Rate in Pediatric Patients (pts) with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (r/r ALL) Treated with Blinatumomab: Rialto an Open-Label, Multicenter, Expanded Access Study

AML SCT-BFM 2007: Results of the Prospective Hematopoietic Stem Cell Transplantation (HCT) Trial of the Berlin-Frankfurt-MÃ¼nster (BFM) Study Group for Children with Very High Risk Acute Myeloid Leukemia

First Results of a Prospective Multicenter Phase I/II Clinical Trial in Adult Patients Using Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning

Safety and Efficacy of Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: Results of a Prospective Multicenter Phase I/II Clinical Trial

Surface HLA-DR Expression in Monocyte Subpopulations During Adverse Events After Hematopoietic Stem Cell Transplantation

Retrospective Analysis of Itraconacole, Voriconazole and Posaconazole As Oral Antifungal Prophylaxis in Pediatric Patients Following Allogeneic Stem Cell Transplantation

Effect of the HDAC Inhibitor SAHA on the Immunmodulatory Properties of MSC and Tumor Stroma Cells.

Adoptive Transfer of EBNA1-Specific T-Cells as a Treatment of Epstein-Barr-Virus Reactivation Following Allogeneic Stem Cell Transplantation

Use of IL15 Stimulated, CD3/19 Depleted Transplants From Haploidentical Donors In Pediatric Malignancies

Siglec-7 Tetramers Characterize B Cell Subpopulations and Identify Immunomodulatory Ligands on Malignant Cells

Patterns of HLA-DR Surface Expression on CD14+ Monocytes During Adverse Events After Hematopoietic Stem Cell Transplantation.

Allogeneic Hematopoetic Stem Cell Transplantation (SCT) In Children with ALL: Outcome of Matched Sibling Donor SCT (MSD-SCT) Is Equivalent to Unrelated Well Matched Donor HSCT (MD-HSCT) A Report From the Prospective International Multicenter Trial ALL-SCT-BFM 2003

Hematopoietic Stem Cell Therapy In Eight Patients with Metachromatic Leukodystrophy – Relevance of Post-Transplant Medication.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only